Failure of estrogen plus progestin therapy for prevention

被引：156

作者：

Fletcher, SW

Colditz, GA

机构：

[1] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA

[2] Harvard Univ, Sch Med, Dept Med, Channing Lab, Boston, MA 02215 USA

[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA

[4] Harvard Pilgrim Hlth Care, Boston, MA USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 288卷 / 03期

关键词：

D O I：

10.1001/jama.288.3.366

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：366 / 368

页数：3

共 20 条

[1]

Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up [J].

Alexander, KP ;

Newby, LK ;

Hellkamp, AS ;

Harrington, RA ;

Peterson, ED ;

Kopecky, S ;

Langer, A ;

O'Gara, P ;

O'Connor, CM ;

Daly, RN ;

Califf, RM ;

Khan, S ;

Fuster, V .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (01) :1-7

[2]

[Anonymous], 2001, PRESCRIPTION DRUG TR

[3]

THE RISK OF BREAST-CANCER AFTER ESTROGEN AND ESTROGEN PROGESTIN REPLACEMENT [J].

BERGKVIST, L ;

ADAMI, HO ;

PERSSON, I ;

HOOVER, R ;

SCHAIRER, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (05) :293-297

[4]

Hormone replacement therapy in relation to breast cancer [J].

Chen, CL ;

Weiss, NS ;

Newcomb, P ;

Barlow, WN ;

White, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (06) :734-741

[5]

THE USE OF ESTROGENS AND PROGESTINS AND THE RISK OF BREAST-CANCER IN POSTMENOPAUSAL WOMEN [J].

COLDITZ, GA ;

HANKINSON, SE ;

HUNTER, DJ ;

WILLETT, WC ;

MANSON, JE ;

STAMPFER, MJ ;

HENNEKENS, C ;

ROSNER, B ;

SPEIZER, FE .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (24) :1589-1593

[6]

The effect of raloxifene on risk of breast cancer in postmenopausal women - Results from the MORE randomized trial [J].

Cummings, SR ;

Eckert, S ;

Krueger, KA ;

Grady, D ;

Powles, TJ ;

Cauley, JA ;

Norton, L ;

Nickelsen, T ;

Bjarnason, NH ;

Morrow, M ;

Lippman, ME ;

Black, D ;

Glusman, JE ;

Costa, A ;

Jordan, VC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (23) :2189-2197

[7]

Treatment of postmenopausal osteoporosis [J].

Delmas, PD .

LANCET, 2002, 359 (9322) :2018-2026

[8]

Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].

Fisher, B ;

Costantino, JP ;

Wickerham, DL ;

Redmond, CK ;

Kavanah, M ;

Cronin, WM ;

Vogel, V ;

Robidoux, A ;

Dimitrov, N ;

Atkins, J ;

Daly, M ;

Wieand, S ;

Tan-Chiu, E ;

Ford, L ;

Wolmark, N .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388

[9]

Cardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II) [J].

Grady, D ;

Herrington, D ;

Bittner, V ;

Blumenthal, R ;

Davidson, M ;

Hlatky, M ;

Hsia, J ;

Hulley, S ;

Herd, A ;

Khan, S ;

Newby, LK ;

Waters, D ;

Vittinghoff, E ;

Wenger, N .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (01) :49-57

[10]

Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study - A prospective, observational study [J].

Grodstein, F ;

Manson, JE ;

Stampfer, MJ .

ANNALS OF INTERNAL MEDICINE, 2001, 135 (01) :1-8

← 1 2 →